Children's Hospital, University of Helsinki and Helsinki University Central Hospital, PB 281, 00029 HUS Helsinki, Finland.
J Clin Endocrinol Metab. 2011 Nov;96(11):3399-407. doi: 10.1210/jc.2011-1493. Epub 2011 Aug 24.
Few monogenic mutations causing human male infertility have been identified to date.
We studied pubertal development and fecundity in males with Mulibrey nanism (MUL) caused by mutations in the TRIM37 gene.
DESIGN, SETTING, AND PATIENTS: Twenty-eight male MUL patients of the Finnish national cohort aged 8.7 to 50.0 yr (median age, 28.8) at the end of observation were followed for 10 yr beginning from 2000-2001.
Clinical characteristics, reproductive hormone levels, semen quality, and testicular histology were assessed.
The external genital phenotype was normal. In childhood and prepuberty, serum levels of FSH, LH, testosterone (T), and inhibin B were normal. Puberty started spontaneously at a median age of 12.6 yr (range, 11.1-15.0), and FSH, LH, T, and inhibin B levels increased adequately until midpuberty. Thereafter, testicular growth and virilization proceeded slowly. Concomitantly, FSH, and to a lesser extent LH, showed a progressive increase to hypergonadotropic levels in all patients, whereas inhibin B decreased and T leveled off. Testicular size was small (median volume, 8.7 ml; range, 3.5-18.3 ml in adults). All semen samples showed severe oligoasthenozoospermia or azoospermia. None of the patients had a history of spontaneous fertility, but four men had undergone infertility treatment, which in one case was successful. All histological MUL samples showed varying degrees of degeneration.
All adult MUL males have a unique disorder of testicular function with small testes, elevated FSH and LH, and low inhibin B. In MUL, mutations in TRIM37 lead to disturbance of sexual maturation, and fertility is severely compromised. Thus, TRIM37 is a novel gene causing male infertility.
迄今为止,已鉴定出少数导致人类男性不育的单基因突变。
我们研究了由 TRIM37 基因突变引起的 Mulibrey 纳米病(MUL)男性的青春期发育和生育能力。
设计、地点和患者:2000-2001 年开始随访,对芬兰国家队列中 28 名 MUL 男性患者进行了 10 年的随访,这些患者的年龄为 8.7 至 50.0 岁(中位年龄 28.8 岁)。
评估临床特征、生殖激素水平、精液质量和睾丸组织学。
外生殖器表型正常。在儿童期和青春期前,FSH、LH、睾酮(T)和抑制素 B 的血清水平正常。青春期中位数年龄为 12.6 岁(范围为 11.1-15.0),FSH、LH、T 和抑制素 B 水平在青春期中期之前充分增加。此后,睾丸生长和男性化进展缓慢。同时,所有患者的 FSH 水平均逐渐升高至促性腺激素水平,而 LH 水平升高程度较轻,而抑制素 B 水平下降,T 水平稳定。睾丸体积较小(成人中位数体积为 8.7ml;范围为 3.5-18.3ml)。所有精液样本均显示严重的少精症或无精症。无患者有自发性生育能力史,但 4 名男性接受了不孕治疗,其中 1 例成功。所有组织学 MUL 样本均显示不同程度的退化。
所有成年 MUL 男性的睾丸功能均存在独特的障碍,表现为睾丸小、FSH 和 LH 升高、抑制素 B 降低。在 MUL 中,TRIM37 基因突变导致性成熟障碍,生育能力严重受损。因此,TRIM37 是导致男性不育的一种新基因。